A

Anika Therapeutics
D

ANIK

21.270
USD
0.09
(0.42%)
Market Open
Volume
221
EPS
0
Div Yield
-
P/E
-92
Market Cap
284,655,687
Overview
Related Instruments
ABT
ABT
D
115.410
1.410(1.23%)
114.000-1.610(-1.39%)
BAX
BAX
D
26.295
-0.110(-0.42%)
BDX
BDX
D
190.490
2.840(1.51%)
I
ICUI
D
182.330
-4.966(-2.65%)
184.000+1.670(+0.92%)
JNJ
JNJ
D
271.70
4.47(1.67%)
267.74-4.50(-1.65%)
MDT
MDT
D
92.390
-1.810(-1.92%)
92.000-0.310(-0.34%)
SYK
SYK
D
329.06
1.52(0.46%)
327.25-1.97(-0.60%)
ZBH
ZBH
D
99.760
0.740(0.75%)
99.500-0.260(-0.26%)
More

Title: Anika Therapeutics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
Smarter Decisions,Together
FacebookTwitterYoutubeLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.